A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fenoldopam
Benzoctamine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Benzoctamine.
Fenoldopam
Captodiame
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Captodiame.
Fenoldopam
Beclamide
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Beclamide.
Fenoldopam
Cyamemazine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Cyamemazine.
Fenoldopam
Etifoxine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Etifoxine.
Fenoldopam
Hexamethonium
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Hexamethonium.
Fenoldopam
Ifenprodil
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Ifenprodil.
Fenoldopam
Amperozide
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Amperozide.
Fenoldopam
Arbaclofen Placarbil
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Arbaclofen Placarbil.
Fenoldopam
Gabapentin enacarbil
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Gabapentin enacarbil.
Fenoldopam
Serotonin
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Serotonin.
Fenoldopam
Tofisopam
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Tofisopam.
Fenoldopam
Cinitapride
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Cinitapride.
Fenoldopam
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when Phenobarbital is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Fenoldopam
Sulthiame
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Sulthiame.
Fenoldopam
Wortmannin
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Wortmannin.
Fenoldopam
Mebutamate
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Mebutamate.
Fenoldopam
Triclofos
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Triclofos.
Fenoldopam
Fospropofol
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Fospropofol.
Fenoldopam
Mepyramine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Mepyramine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3